pillbase.ru

Эфтенла

Active substance: Ламивудин, Тенофовир, Эфавиренз

таблетки, покрытые пленочной оболочкой, 300 мг+300 мг+600 мг (original in Russian, GRLS)

RussiaActive

Marketing holder: Акционерное общество "Фармасинтез" (АО "Фармасинтез")

Verified 2026-10-09 · GRLS (Russian state register)

Analogues in other countries
Composition
Products containing lamivudine in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
US 53
  • ABACAVIR and LAMIVUDINE
    TABLET, FILM COATED · ABACAVIR SULFATE 600 mg/1, LAMIVUDINE 300 mg/1
    31722-838
    Camber Pharmaceuticals, Inc.
  • ABACAVIR, LAMIVUDINE AND ZIDOVUDINE
    TABLET · LAMIVUDINE 150 mg/1, ZIDOVUDINE 300 mg/1, ABACAVIR SULFATE 300 mg/1
    68180-286
    Lupin Pharmaceuticals, Inc.
  • Abacavir and Lamivudine
    TABLET, FILM COATED · ABACAVIR SULFATE 600 mg/1, LAMIVUDINE 300 mg/1
    68180-288
    Lupin Pharmaceuticals, Inc.
  • Abacavir and Lamivudine
    TABLET, FILM COATED · ABACAVIR SULFATE 600 mg/1, LAMIVUDINE 300 mg/1
    33342-440
    Macleods Pharmaceuticals Limited
  • Abacavir and Lamivudine
    TABLET, FILM COATED · ABACAVIR SULFATE 600 mg/1, LAMIVUDINE 300 mg/1
    65862-335
    Aurobindo Pharma Limited
All products in this country (53)
EU 12
  • Combivir
    lamivudine, zidovudine
    EMEA/H/C/000190
    ViiV Healthcare BV
  • Delstrigo
    doravirine, lamivudine, tenofovir disoproxil fumarate
    EMEA/H/C/004746
    Merck Sharp & Dohme B.V.
  • Dovato
    dolutegravir sodium, lamivudine
    EMEA/H/C/004909
    ViiV Healthcare B.V.
  • Epivir
    lamivudine
    EMEA/H/C/000107
    ViiV Healthcare BV
  • Kivexa
    abacavir, lamivudine
    EMEA/H/C/000581
    ViiV Healthcare BV
All products in this country (12)
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-397d-767a-b896-70baaf32d509,01a120c3-3eb2-720d-96d0-26034ced2ff5,01a120c3-4146-7719-8056-f4be8450b4bc,01a120c3-4416-740a-95b6-c025ec9581cf,01a120c3-4a43-779b-b1cb-af99d70a953b;count=47 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-8481-7076-abd3-8bb5dd6a49d8,01a1208d-7a49-730c-a993-8750076b7fe3,01a1208d-8cfa-7da0-b9b2-9539a181c6cf,01a1208d-94f5-7cf5-9063-d62c05ce0f4e,01a1208e-16f1-75e3-8269-bd03dd3cafc2;count=29 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
ЛП-006559
Registration status
Active
Dispensing
Prescription only
Release forms
таблетки, покрытые пленочной оболочкой, 300 мг+300 мг+600 мг, 30 шт. - банки - пачки картонные (30 шт.) - По рецепту; show all (2)таблетки, покрытые пленочной оболочкой, 300 мг+300 мг+600 мг, 30 шт. - банки - пачки картонные (30 шт.) - По рецепту; таблетки, покрытые пленочной оболочкой, 300 мг+300 мг+600 мг, 10 шт. - упаковки ячейковые контурные (3 шт.) - пачки картонные (30 шт.) - По рецепту;
(original in Russian, GRLS)
Sources
  • product · GRLS (Russian state register) · ЛП-006559 · Verified 2026-10-09
  • registration_status · GRLS (Russian state register) · ЛП-006559 · Verified 2026-10-09
  • ingredients.0 · GRLS (Russian state register) · ЛП-006559 · Verified 2026-10-09
  • ingredients.1 · GRLS (Russian state register) · ЛП-006559 · Verified 2026-10-09
  • ingredients.2 · GRLS (Russian state register) · ЛП-006559 · Verified 2026-10-09